Stem Cell Manufacturing Market Size, Share, Trends, Value 2030

Stem Cell Manufacturing Market

Stem Cell Manufacturing Market- By Product (Consumables, Instrument, HSCs, MSCs, iPSCs, and ESCs), By Application (Clinical Research and Cell & Tissue Banking), By End User (Pharma & Biotech, Hospitals, and Tissue Bank), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2028

Category: Biotechnology Report Format : PDF Pages: 124 Report Code: ZMR-6478 Published Date: Jul-2021 Status : Published
Market Size in 2020 Market Forecast in 2028 CAGR (in %) Base Year
USD 11.2 Billion USD 21.1 Billion 9.5% 2020

The global Stem Cell Manufacturing market accrued earnings worth approximately 11.2(USD Billion) in 2020 and is predicted to gain revenue of about 21.1(USD Billion) by 2028, is set to record a CAGR of nearly 9.5% over the period from 2021 to 2028.

The report offers assessment and analysis of the Stem Cell Manufacturing market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).

Stem Cell Manufacturing Market: Overview

Stem cells possess huge potential for developing new cell treatments for unfulfilled medical requirements. Moreover, key aim of producing cell-based products is to manufacture large amounts of viable, healthy, and phenotypically as well as genotypically stable cells, and the production of stem cells is no exception to this. Apart from this, industry players focus on devising stem cell manufacturing processes in such a way that the latter must fulfill the goals of producing a large number of healthy as well as phenotypically & genotypically stable cells.  

Moreover, stem cells, which are also referred to as Mesenchymal stem cells, are isolated by utilizing classic methods like ficoll gradient centrifugation as well as consequent cell fraction plating. Apart from this, Mesenchymal stem cells are adherent and can be easily separated from other kinds of cells in the initial phase of cell isolation through cell attachment in 2D tissue cell culture flasks.

Global Stem Cell Manufacturing MarketRequest Free Sample

Additionally, stem cells are utilized in allogenic or autologous approaches for manufacturing a cell lot that can manufacture multiple cell-based product units. In an autologous approach, stem cells are processed, harvested, and expanded and after that reintroduced into patients.  Apparently, the use of the autologous method results in enhancing manufacturing controls in a regulated environment leading to the huge production of stem cells along with cost reduction & improved purity of cell-based products.

Stem Cell Manufacturing Market: Growth Dynamics

Humungous use of stem cells for treating myriad kinds of ailments will steer the growth of the stem cell manufacturing market over the upcoming years. Additionally, surging funding of stem-cell research activities, escalating awareness pertaining to the therapeutic potential of stem cell-based products, and favorable laws supporting stem-cell research in emerging economies will boost market trends. Large-scale awareness about treating cancer, degenerative ailments, and hematopoietic diseases through stem cell therapies will embellish market size over the assessment period. The rise in research activities in the pharma & biotech industries will provide impetus to the stem cell treatment market, thereby driving stem cell manufacturing market value over the years to come.

Stem Cell Manufacturing Market: Report Scope

Report Attributes Report Details
Report Name Stem Cell Manufacturing Market Research Report
Market Size in 2020 USD 11.2 Billion
Market Forecast in 2028 USD 21.1 Billion
Growth Rate CAGR of 9.5%
Number of Pages 210
Key Companies Covered Thermo Fisher Scientific, Inc., Lonza Group AG, Sartorius AG, Merck Milliopore, and Danahar Corporation.
Segments Covered By Deployment Mode, By Vertical, By Component, By Organization Size and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2020
Historical Year 2018 to 2020
Forecast Year 2021 - 2028
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Furthermore, the delivery of cell-based treatments to market poses a unique risk in terms of both security & efficiency, and hence the massive acceptance of the risk-based model in the pharma sector has gained momentum in recent years. This is anticipated to create lucrative growth avenues for the stem cell manufacturing industry over the years to come. In addition to this, stem cells are garnering immense popularity due to their major role in effective disease management & specialized research events such as genomic testing & personalized drugs. This, in turn, will help the stem cell manufacturing business expand by leaps & bounds during the upcoming years.

Competitive Landscape

Stem cell manufacturing industry share is highly fragmented due to presence of giant players & new entrants. With need to establish competitive advantage, players in the market are trying to launch new stem cell manufacturing processes. Few of key players profiled in the study and leveraging market growth are Thermo Fisher Scientific, Inc., Lonza Group AG, Sartorius AG, Merck Milliopore, and Danahar Corporation.

Regional Landscape

North America Accounts Majorly Towards Overall Market Size By 2028

The growth of the stem cell manufacturing market in North America Over the forecast period is due to massive stem cell research activities in countries such as the U.S. In addition to this, easy access to private-public funding as well as government support for stem cell research & applications in Canada and the U.S. will proliferate regional market size.

Global Stem Cell Manufacturing Market SizeRequest Free Sample

The rise in cell treatment and gene therapies in the sub-continent will boost the production of stem cells for biotech & clinical research as well as for human & animal trials, thereby paving way for the growth of stem cell manufacturing business in the sub-continent of North America. The presence of major participants in countries such as the U.S. and Canada will further enlarge the regional market scope in the upcoming years.

Stem Cell Manufacturing Market: Competitive Space

The global Stem Cell Manufacturing market profiles key players such as:

  • Thermo Fisher Scientific, Inc
  • Lonza Group AG
  • Sartorius AG
  • Merck Milliopore
  • Danahar Corporation

The global Stem Cell Manufacturing Market is segmented as follows:

By End-User

By Application

  • Clinical Research
  • Cell & Tissue Banking

By Product

  • Consumables
  • Instrument
  • HSCs
  • MSCs
  • iPSCs
  • ESCs

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Humungous use of stem cells for treating myriad kind of ailments will steer growth of stem cell manufacturing market over the upcoming years. Additionally, surging funding of stem-cell research activities, escalating awareness pertaining to therapeutic potential of stem cell-based products, and favorable laws supporting stem cell research in emerging economies will boost market trends. Large-scale awareness about treating cancer, degenerative ailments, and hematopoietic diseases through stem cell therapies will embellish market size over assessment period. Rise in research activities in pharma & biotech industries will provide impetus to stem cell treatment market, thereby driving stem cell manufacturing market value over the years to come.

Furthermore, delivery of cell-based treatments to market poses a unique risk in terms of both security & efficiency and hence massive acceptance of risk-based model in pharma sector has gained momentum in recent years. This is anticipated to create lucrative growth avenues for stem cell manufacturing industry over the years to come.  

According to Zion market research report, the global Stem Cell Manufacturing market accrued earnings worth approximately 11.2(USD Billion) in 2020 and is predicted to gain revenue of about 21.1(USD Billion) by 2028, is set to record a CAGR of nearly 9.5% over the period from 2021 to 2028.

North America will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is due to massive stem cell research activities in countries such as the U.S. In addition to this, easy access to private-public funding as well as government support for stem cell research & applications in Canada and the U.S. will proliferate regional market size. Rise in cell treatment and gene therapies in the sub-continent will boost production of stem cells for biotech & clinical research as well as for human & animal trials, thereby paving way for growth of stem cell manufacturing business in sub-continent of North America. Presence of major participants in countries such as the U.S. and Canada will further enlarge regional market scope in upcoming years.  

 

 

The key market participants include Thermo Fisher Scientific, Inc., Lonza Group AG, Sartorius AG, Merck Milliopore, and Danahar Corporation.

Key applications of stem cell manufacturing include cancerous tissues, genetic disorders, degenerative ailments, and hematopoietic diseases. It also provides impetus to genomic testing activities and facilitates research in personalized medicine sector.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed